ONCT
Oncternal Therapeutics Inc
Price:  
0.53 
USD
Volume:  
219,462.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ONCT EV/EBITDA

-38940.2%
Upside

As of 2025-06-13, the EV/EBITDA ratio of Oncternal Therapeutics Inc (ONCT) is 0.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ONCT's latest enterprise value is -11.52 mil USD. ONCT's TTM EBITDA according to its financial statements is -35.96 mil USD. Dividing these 2 quantities gives us the above ONCT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.6x - 14.1x 13.8x
Forward P/E multiples 17.9x - 32.2x 20.6x
Fair Price (213.28) - (166.63) (204.53)
Upside -40601.2% - -31742.5% -38940.2%
0.53 USD
Stock Price
(204.53) USD
Fair Price

ONCT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA